陳 雅萍

Medicine & Life Sciences

1. Lymphoma, Large B-Cell, Diffuse 100%
2. Neoplasms 53%
3. Precursor Cell Lymphoblastic Leukemia-Lymphoma 49%
4. Drug Therapy 45%
5. Lymphoma 44%
6. Follicular Lymphoma 42%
7. B-Cell Lymphoma 42%
8. T-Cell Lymphoma 38%
9. Epstein-Barr virus EBV-associated membrane antigen 38%
10. Type I Bare Lymphocyte Syndrome 36%
11. B-Lymphocytes 33%
12. Bone Marrow 33%
13. Dengue Virus 32%
14. RV 538 28%
15. Typhlitis 28%
16. T-Lymphocytes 28%
17. Hemophagocytic Lymphohistiocytosis 28%
18. Glycogen Synthase Kinase 3 28%
19. interleukin 20 27%
20. ceramide glucosyltransferase 26%
21. arginine deiminase 26%
22. Mycobacterium kansasii 26%
23. Lymphocytes 26%
24. Peripheral T-Cell Lymphoma 24%
25. Klebsiella oxytoca 24%
26. Aurora Kinase A 24%
27. Therapeutics 24%
28. Membrane Proteins 24%
29. Agammaglobulinaemia Tyrosine Kinase 24%
30. Immunotherapy 23%
31. Platelet-Derived Growth Factor alpha Receptor 23%
32. Chelation Therapy 23%
33. Glucosephosphate Dehydrogenase Deficiency 23%
34. Mycobacterium Infections 22%
35. Polyethyleneimine 22%
36. Thrombotic Thrombocytopenic Purpura 22%
37. Rituximab 21%
38. Lymphadenopathy 21%
39. Hemangiosarcoma 20%
40. Fever 20%